Rubin Lab


American College of Gastroenterology
2019 ACG Guidelines: Rubin DT, et al. Am J Gastroenterol. 2019;114(3):384-413.
2017 ACG Guidelines (Preventive Care in IBD): Farraye FA, et al. Am J Gastroenterol. 2017;112:241-258.

American Gastroenterological Association
2020 AGA Guidelines (Moderate-to-Severe UC): Feuerstein JD, et al. Gastroenterology. 2020. 
2019 AGA Guidelines (Mild-to-Moderate UC): Ko CW, et al. Gastroenterology. 2019; 156(3):748-764.
2017 AGA Guidelines (Therapeutic Drug Monitoring): Feuerstein JD, et al. Gastroenterology. 2017; 153(3):827-834.
2015 AGA Ulcerative Colitis Care Pathway: Dassopoulos T, et al. Gastroenterology. 2015;149(1):238-45.
2010 AGA Position Statement (Colorectal Neoplasia in IBD): Farraye FA, et al. Gastroenterology. 2010;138:738-745.

Canadian Association of Gastroenterology
2016 Toronto Consensus Statement (Pregnant IBD Patients): Nguyen GC, et al.Gastroenterology. 2016;150(3):734-757.
2015 Toronto Consensus Guidelines (Non-Hospitalized): Bressler B, et al. Gastroenterology. 2015;148(5):1035-1058.e3.
2012 Toronto Consensus Statement (Hospitalized): Bitton A, et al. Am J Gastroenterol. 2012;107(2):179-94.

American Society of Gastrointestinal Endoscopy
2015 ASGE Guidelines (Endoscopy in IBD): Shergill AK, et al. Gastrointest Endosc. 2015;81(5):1101-1121.e13.

American Society of Colon and Rectal Surgeons
2014 ASCRS Guidelines (UC Surgical Treatment): Ross H, et al. Dis Colon Rectum. 2014;57(1):5-22.

European Crohn’s and Colitis Organization Guidelines
2018 Guidelines for Pediatric Management (with ESPGHAN):
Turner D, et al. J Pediatr Gastroenterol Nutr. 2018;67(2):257-291.
Turner D, et al. J Pediatr Gastroenterol Nutr. 2018;67(2):292-310.
2018 Guidelines for Diagnostic Assessment in IBD (with ESGAR):
Maaser C, et al. J Crohns Colitis. 2018;13(2):144-164.
Sturm A, et al. J Crohns Colitis. 2019;13(3):273-284.
2018 Consensus Statement (Nursing Roles): Kemp K, et al. J Crohns Colitis. 2018;12(7):760-776.
2017 Consensus Statement (UC Management in Adults):
Hardbord M, et al. J Crohns Colitis. 2017;11(7):769-784.
Magro F, et al. J Crohns Colitis. 2017;11(6):649-670.
2016 Consensus Statement (Extra-intestinal Manifestations in UC): Hardbord M, et al. J Crohns Colitis. 2016;10(3):239-254.
2015 Consensus Statement (Surgery for UC): Øresland T, et al. J Crohns Colitis. 2015;9(1):4-25.
2015 Consensus Statement (IBD Malignancies): Annese V, et al. J Crohns Colitis. 2015;9(11):945-965.
2015 Consensus Statement (Iron Deficiency/Anemia in IBD): Dignass AU, et al. J Crohns Colitis. 2015;9(3):211-222.
2015 Consensus Statement (Reproduction/Pregnancy in IBD): Van de Woude  CJ, et al. J Crohns Colitis. 2015;9(2):107-124.
2014 Consensus Statement (Opportunistic Infections in IBD): Rahier JF, et al. J Crohns Colitis. 2014;9(2):443-468.
2013 Consensus Statement (Special Situations): Van Assche G, et al. J Crohns Colitis. 2013;7(1):1-33.
2013 Consensus Statement (Endoscopy in IBD): Annese V, et al. J Crohns Colitis. 2013;7(12):982-1018.
2013 Consensus Statement (Histopathology of IBD): Magro F, et al. J Crohns Colitis. 2013;7(10):827-851.
2013 Consensus Statement (Imaging in IBD with ESGAR): Panes J, et al. J Crohns Colitis. 2013;7(7):556-585.
2013 Position Statement (Biosimilars in IBD): Danese S, et al. J Crohns Colitis.2013;7(7):586-9.

Other International Guidelines
2018 GETECCU Guidelines on Thiopurines: Bermejo F, et al. Gastroenterol Hepatol. 2018;41(3):205-221.
2018 GETECCU and ACCU Guidelines on Psychological Issues in IBD: Barreiro-de Acosta M, et al. Gastroenterol Hepatol. 2018;41(2):118-127.
2018 ACPGBI Consensus Guidelines (Surgery in IBD): Brown SR, et al.Colorectal Dis. 2018;20 (Suppl8):3-117.
2017 Belgian IBD Research Group Position Statement on Biosimilars: Franchimont D, et al. Acta Gastroenterol Belg. 2018;81(1):49-53.
2017 Korean Association for Study IBD Guidelines: Coi CH, et al. Intest Res. 2017; 15(1): 7–37.
2017 Taiwan Society of IBD Consensus Guidelines (UC Management): Wei CS, et al. IntestRes.2017;15(3): 266–284.
2017 ESPEN Guidelines (Nutrition in IBD): Forbes A, et al. Clin Nutr. 2017;36(2):321-347.
2016 ANGH/CREGG/GETAID Consensus Guidelines (UC Management): Peyrin-Biroulet L, et al. Dig Liver Dis.2016;48(7):726-33.
2015 SCENIC Consensus Statement: Laine L, et al. Gastrointest Endosc. 2015;81(3):489-501.e26.
2015 WGO Global IBD Guidelines:
2014 Italian Group for IBD Position Statement on Biosimilars: Annese V, et al. Dig Liver Dis. 2014;46(11):963-8.
2013 NICE Guidelines (UC Management): Stenke E, et al. Arch Dis Child EducPractEd. 2014;99(5):194-7.
2011 NICE Guidelines (Colorectal Cancer Prevention): NICE Clinical Guidelines, No. 118. Centre for Clinical Practice at NICE (UK).London: National Institute for Health and Clinical Excellence (UK); 2011.
2013 BSG Guidelines on Biopsies: Feakins RM, et al. J Clin Pathol. 2013;66(12):1005-26.
2011 BSG Guidelines on IBD Management: Mowat C, et al. Gut. 2011;60(5):571-607.
2011 SIGE/IG-IBD Guidelines (Anti-TNF Therapy in IBD): Orlando A, et al. Dig Liver Dis. 2011;43(1):1-20.
2010 GESA Guidelines (Anti-TNF Therapy in IBD): Connell W, et al. Intern Med J. 2010;40(2):139-49.
2010 Brazilian Study Group of IBD Consensus Guidelines on IBD Management: Brazilian Study Group of Inflammatory Bowel Diseases. ArqGastroenterol. 2010;47(3):313-25.
2010 Asia-Pacific Consensus Statement: Ooi CJ, et al. J Gastroenterol Hepatol. 2010;25(3):453-68.

Crohn’s and Colitis Foundation Health Maintenance Checklist
Cornerstones Health Checklist